BIIB vs MBI · P/E 21, rev $9.89B vs rev $51.0M
Biogen Inc (BIIB) versus MBIA Inc (MBI) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
MBIA Inc (MBI) is a insurance - specialty company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported MBI revenue for 2026-06-30 was $51.0M. Net income was -$85.0M. MBI currently screens at market cap $321.4M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. MBI currently screens at market cap $321.4M.
Not investment advice. Open the BIIB and MBI stock pages for the full models.
Not investment advice.